Patent Leaderboard
USPTO Patent Rankings Data through Dec 31, 2025
Home › Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors

Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors

US Patent 11110055 · Granted Sep 7, 2021

Assignee

Inventors

View full patent text on Google Patents →

More Patents by These Inventors

Silk-based product formulations and methods of use2025
Methods of making stable silk fibroin formulations2024
Methods for reducing impurities in silk fibroin preparations2024
Pharmaceutical compositions comprising venglustat2024
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023
Pharmaceutical formulations of tropomyosin related kinase (TRK) inhibitors2023
Ocular applications of silk-based products2023
Silk-based product formulations and methods of use2023
Pharmaceutical formulations of tropomyosin related kinase (Trk) inhibitors2019